The Hemato Oncology Testing Market is on the verge of a significant transformation, projected to reach a remarkable USD 10.21 billion by 2035, growing from USD 4.0 billion in 2024. This remarkable growth reflects a compound annual growth rate (CAGR) of 8.89%. The heightened scrutiny on hematological malignancies and the push for personalized medicine are pivotal forces driving this expansion....
Bangla